Mei-Shi Subsidiary Lotus Pharma Bulgaria EOOD Announces Fund Lending to Parent Company
NQ Score
77/100
N1 Content Completeness
9
AI Summary (NQ-processed)
Lotus Pharma Bulgaria EOOD, a subsidiary of Mei-Shi, announced a new fund lending of USD 21 million (approximately TWD 663 million) to its parent company Lotus International Pte. Ltd. for operational working capital, with interest based on 3-month SOFR plus 1.3%.
AI Analysis
Frequently Asked Questions
- Q: Who is the recipient of the fund lending?
- A: The recipient is Lotus International Pte. Ltd., the parent company of Mei-Shi, based in Singapore.
- Q: What is the amount of this lending?
- A: The new lending amount is USD 21 million (approx. TWD 663 million), converted at 31.575 TWD/USD on June 17, 115.
- Q: Is there any collateral?
- A: No collateral has been provided for this lending; the collateral value is zero.
- Q: How is the interest rate determined?
- A: The interest rate is based on 3-month SOFR plus 1.3%.
- Q: What is the repayment period?
- A: The contract term is five years, starting from the first disbursement date.